SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Monoj Mon Kalita, Stephen Griffin, James J. Chou, Wolfgang B. Fischer, Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2015, 1848, 6, 1383

    CrossRef

  2. 2
    Stanley J Opella, Relating structure and function of viral membrane-spanning miniproteins, Current Opinion in Virology, 2015, 12, 121

    CrossRef

  3. 3
    Albert Konijnenberg, Ludovic Bannwarth, Duygu Yilmaz, Armağan Koçer, Catherine Venien-Bryan, Frank Sobott, Top-down mass spectrometry of intact membrane protein complexes reveals oligomeric state and sequence information in a single experiment, Protein Science, 2015, 24, 8
  4. 4
    Claire Scott, Stephen Griffin, Viroporins: structure, function and potential as antiviral targets, Journal of General Virology, 2015, 96, 8, 2000

    CrossRef

  5. 5
    Stephen Griffin, “Too little, too late?” Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?, Future Medicinal Chemistry, 2014, 6, 17, 1893

    CrossRef

  6. 6
    Leon Bichmann, Yi-Ting Wang, Wolfgang B. Fischer, Docking assay of small molecule antivirals to p7 of HCV, Computational Biology and Chemistry, 2014, 53, 308

    CrossRef

  7. 7
    Yi-Ting Wang, Roman Schilling, Rainer H.A. Fink, Wolfgang B. Fischer, Ion-dynamics in hepatitis C virus p7 helical transmembrane domains — a molecular dynamics simulation study, Biophysical Chemistry, 2014, 192, 33

    CrossRef

  8. 8
    Ali M. Atoom, Nathan G.A. Taylor, Rodney S. Russell, The elusive function of the hepatitis C virus p7 protein, Virology, 2014, 462-463, 377

    CrossRef

  9. 9
    Elizabeth Atkins, Ranjitha Tatineni, Hui Li, David Gretch, Mark Harris, Stephen Griffin, The stability of secreted, acid-labile H77/JFH-1 hepatitis C virus (HCV) particles is altered by patient isolate genotype 1a p7 sequences, Virology, 2014, 448, 117

    CrossRef

  10. 10
    Mark Harris, Hepatitis C virus, eLS,